Aperio Group’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-48,136
| Closed | -$4.09M | – | 2452 |
|
|
2019
Q4 | $4.09M | Buy |
48,136
+4,144
| +9% | +$276K | 0.01% | 814 |
|
|
2019
Q3 | $2.2M | Sell |
43,992
-1,673
| -4% | -$66.7K | 0.01% | 1009 |
|
|
2019
Q2 | $1.67M | Buy |
45,665
+4,796
| +12% | +$157K | 0.01% | 1149 |
|
|
2019
Q1 | $1.14M | Buy |
40,869
+8,957
| +28% | +$211K | ﹤0.01% | 1304 |
|
|
2018
Q4 | $611K | Buy |
31,912
+4,003
| +14% | +$93.1K | ﹤0.01% | 1570 |
|
|
2018
Q3 | $835K | Sell |
27,909
-104
| -0.4% | -$3.92K | ﹤0.01% | 1510 |
|
|
2018
Q2 | $1.03M | Buy |
28,013
+2,203
| +9% | +$71.6K | ﹤0.01% | 1375 |
|
|
2018
Q1 | $851K | Buy |
25,810
+442
| +2% | +$13.8K | ﹤0.01% | 1416 |
|
|
2017
Q4 | $694K | Buy |
25,368
+1,452
| +6% | +$44.7K | ﹤0.01% | 1534 |
|
|
2017
Q3 | $886K | Sell |
23,916
-5,057
| -17% | -$186K | 0.01% | 1346 |
|
|
2017
Q2 | $1.1M | Buy |
28,973
+5,903
| +26% | +$263K | 0.01% | 1188 |
|
|
2017
Q1 | $1.13M | Sell |
23,070
-1,009
| -4% | -$46K | 0.01% | 1115 |
|
|
2016
Q4 | $817K | Buy |
24,079
+174
| +0.7% | +$6.17K | 0.01% | 1221 |
|
|
2016
Q3 | $903K | Buy |
23,905
+4,570
| +24% | +$172K | 0.01% | 1151 |
|
|
2016
Q2 | $650K | Sell |
19,335
-145
| -0.7% | -$5.11K | 0.01% | 1259 |
|
|
2016
Q1 | $619K | Buy |
19,480
+1,361
| +8% | +$44.4K | 0.01% | 1262 |
|
|
2015
Q4 | $677K | Buy |
18,119
+1,568
| +9% | +$59.3K | 0.01% | 1190 |
|
|
2015
Q3 | $628K | Buy |
16,551
+1,246
| +8% | +$43.7K | 0.01% | 1184 |
|
|
2015
Q2 | $438K | Sell |
15,305
-137
| -0.9% | -$3.82K | ﹤0.01% | 1402 |
|
|
2015
Q1 | $433K | Buy |
15,442
+2,925
| +23% | +$82.2K | ﹤0.01% | 1355 |
|
|
2014
Q4 | $346K | Buy |
+12,517
| New | +$310K | ﹤0.01% | 1422 |
|
|
2014
Q3 | – | Sell |
-9,553
| Closed | -$278K | – | 1779 |
|
|
2014
Q2 | $278K | Sell |
9,553
-1,185
| -11% | -$31.6K | ﹤0.01% | 1433 |
|
|
2014
Q1 | $305K | Buy |
+10,738
| New | +$355K | ﹤0.01% | 1609 |
|
|
2013
Q4 | – | Sell |
-9,977
| Closed | -$357K | – | 1366 |
|
|
2013
Q3 | $334K | Buy |
9,977
+236
| +2% | +$7.52K | 0.01% | 1357 |
|
|
2013
Q2 | $300K | Buy |
+9,741
| New | +$326K | 0.01% | 1268 |
|
Other funds holding MDCO
Aperio Group's MDCO Position: Q1 2020 in Review
Aperio Group sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 48,136 shares — an estimated $4.09M sold.
Aperio Group first reported a position in MDCO in Q2 2013 and held it in 25 quarters. The position peaked at $4.09M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Aperio Group reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Aperio Group sold 48,136 Medicines Co shares in Q1 2020, an estimated $4.09M.
- Aperio Group first reported a position in Medicines Co in Q2 2013 and held it in 25 quarters.
- Aperio Group's Medicines Co position peaked at $4.09M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Aperio Group's 13F filing for Q1 2020, filed 5 May 2020.